 | • レポートコード：GIR201107049 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、多関節若年性特発性関節炎薬の世界市場を調査対象にし、多関節若年性特発性関節炎薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Biocon Ltd、Panacea Biotec Ltd、Momenta Pharmaceuticals Inc、Coherus BioSciences Inc、Oncodesign SA、Livzon Pharmaceutical Group Inc、Sandoz International GmbH、Oncobiologics Inc、Mycenax Biotech Inc、Regeneron Pharmaceuticals Inc、UCB SA ・メーカー別販売量、売上、市場シェア ・多関節若年性特発性関節炎薬の地域別市場分析 ・多関節若年性特発性関節炎薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・多関節若年性特発性関節炎薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・多関節若年性特発性関節炎薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・多関節若年性特発性関節炎薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・多関節若年性特発性関節炎薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・多関節若年性特発性関節炎薬の種類別市場規模2015-2020：エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他 ・多関節若年性特発性関節炎薬の用途別市場規模2015-2020：病院、クリニック、その他 ・多関節若年性特発性関節炎薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Polyarticular Juvenile Idiopathic Arthritis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Polyarticular Juvenile Idiopathic Arthritis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Polyarticular Juvenile Idiopathic Arthritis Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Polyarticular Juvenile Idiopathic Arthritis Drug market has been segmented into
Etanercept Biosimilar
Tocilizumab Biosimilar
Sarilumab
Adalimumab Biosimilar
Others
By Application, Polyarticular Juvenile Idiopathic Arthritis Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Polyarticular Juvenile Idiopathic Arthritis Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Polyarticular Juvenile Idiopathic Arthritis Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Polyarticular Juvenile Idiopathic Arthritis Drug market.
The report offers in-depth assessment of the growth and other aspects of the Polyarticular Juvenile Idiopathic Arthritis Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Polyarticular Juvenile Idiopathic Arthritis Drug Market Share Analysis
Polyarticular Juvenile Idiopathic Arthritis Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Polyarticular Juvenile Idiopathic Arthritis Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Polyarticular Juvenile Idiopathic Arthritis Drug sales, revenue and market share for each player covered in this report.
The major players covered in Polyarticular Juvenile Idiopathic Arthritis Drug are:
Biocon Ltd
Panacea Biotec Ltd
Momenta Pharmaceuticals Inc
Coherus BioSciences Inc
Oncodesign SA
Livzon Pharmaceutical Group Inc
Sandoz International GmbH
Oncobiologics Inc
Mycenax Biotech Inc
Regeneron Pharmaceuticals Inc
UCB SA
Among other players domestic and global, Polyarticular Juvenile Idiopathic Arthritis Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polyarticular Juvenile Idiopathic Arthritis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polyarticular Juvenile Idiopathic Arthritis Drug, with price, sales, revenue and global market share of Polyarticular Juvenile Idiopathic Arthritis Drug in 2018 and 2019.
Chapter 3, the Polyarticular Juvenile Idiopathic Arthritis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polyarticular Juvenile Idiopathic Arthritis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Polyarticular Juvenile Idiopathic Arthritis Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Polyarticular Juvenile Idiopathic Arthritis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Polyarticular Juvenile Idiopathic Arthritis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Etanercept Biosimilar
1.2.3 Tocilizumab Biosimilar
1.2.4 Sarilumab
1.2.5 Adalimumab Biosimilar
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Polyarticular Juvenile Idiopathic Arthritis Drug Market
1.4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Biocon Ltd
2.1.1 Biocon Ltd Details
2.1.2 Biocon Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biocon Ltd SWOT Analysis
2.1.4 Biocon Ltd Product and Services
2.1.5 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Panacea Biotec Ltd
2.2.1 Panacea Biotec Ltd Details
2.2.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Panacea Biotec Ltd SWOT Analysis
2.2.4 Panacea Biotec Ltd Product and Services
2.2.5 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Momenta Pharmaceuticals Inc
2.3.1 Momenta Pharmaceuticals Inc Details
2.3.2 Momenta Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Momenta Pharmaceuticals Inc SWOT Analysis
2.3.4 Momenta Pharmaceuticals Inc Product and Services
2.3.5 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Coherus BioSciences Inc
2.4.1 Coherus BioSciences Inc Details
2.4.2 Coherus BioSciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Coherus BioSciences Inc SWOT Analysis
2.4.4 Coherus BioSciences Inc Product and Services
2.4.5 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Oncodesign SA
2.5.1 Oncodesign SA Details
2.5.2 Oncodesign SA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Oncodesign SA SWOT Analysis
2.5.4 Oncodesign SA Product and Services
2.5.5 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Livzon Pharmaceutical Group Inc
2.6.1 Livzon Pharmaceutical Group Inc Details
2.6.2 Livzon Pharmaceutical Group Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Livzon Pharmaceutical Group Inc SWOT Analysis
2.6.4 Livzon Pharmaceutical Group Inc Product and Services
2.6.5 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sandoz International GmbH
2.7.1 Sandoz International GmbH Details
2.7.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sandoz International GmbH SWOT Analysis
2.7.4 Sandoz International GmbH Product and Services
2.7.5 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Oncobiologics Inc
2.8.1 Oncobiologics Inc Details
2.8.2 Oncobiologics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Oncobiologics Inc SWOT Analysis
2.8.4 Oncobiologics Inc Product and Services
2.8.5 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mycenax Biotech Inc
2.9.1 Mycenax Biotech Inc Details
2.9.2 Mycenax Biotech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mycenax Biotech Inc SWOT Analysis
2.9.4 Mycenax Biotech Inc Product and Services
2.9.5 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Regeneron Pharmaceuticals Inc
2.10.1 Regeneron Pharmaceuticals Inc Details
2.10.2 Regeneron Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Regeneron Pharmaceuticals Inc SWOT Analysis
2.10.4 Regeneron Pharmaceuticals Inc Product and Services
2.10.5 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 UCB SA
2.11.1 UCB SA Details
2.11.2 UCB SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 UCB SA SWOT Analysis
2.11.4 UCB SA Product and Services
2.11.5 UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
4.3 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
4.5 South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
5.3 Canada Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
6.3 UK Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
6.4 France Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
6.5 Russia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
6.6 Italy Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
7.3 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
7.4 Korea Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
7.5 India Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
7.7 Australia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Market Share by Type (2015-2020)
10.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price by Type (2015-2020)
11 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Segment by Application
11.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application (2015-2020)
11.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Application (2015-2020)
11.3 Global Polyarticular Juvenile Idiopathic Arthritis Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025)
12.2.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025)
12.2.4 South America Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025)
12.3 Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Type (2021-2025)
12.3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share Forecast by Type (2021-2025)
12.4 Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast by Application (2021-2025)
12.4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Polyarticular Juvenile Idiopathic Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 9. Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 10. Biocon Ltd SWOT Analysis
Table 11. Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 12. Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 15. Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 16. Panacea Biotec Ltd SWOT Analysis
Table 17. Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 18. Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Momenta Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 21. Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 22. Momenta Pharmaceuticals Inc SWOT Analysis
Table 23. Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 24. Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Coherus BioSciences Inc Basic Information, Manufacturing Base and Competitors
Table 26. Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 27. Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 28. Coherus BioSciences Inc SWOT Analysis
Table 29. Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 30. Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Oncodesign SA Basic Information, Manufacturing Base and Competitors
Table 32. Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 33. Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 34. Oncodesign SA SWOT Analysis
Table 35. Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 36. Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Livzon Pharmaceutical Group Inc Basic Information, Manufacturing Base and Competitors
Table 38. Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 39. Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 40. Livzon Pharmaceutical Group Inc SWOT Analysis
Table 41. Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 42. Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 45. Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 46. Sandoz International GmbH SWOT Analysis
Table 47. Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 48. Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Oncobiologics Inc Basic Information, Manufacturing Base and Competitors
Table 50. Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 51. Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 52. Oncobiologics Inc SWOT Analysis
Table 53. Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 54. Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Mycenax Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 56. Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 57. Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 58. Mycenax Biotech Inc SWOT Analysis
Table 59. Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 60. Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 62. Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 63. Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 64. Regeneron Pharmaceuticals Inc SWOT Analysis
Table 65. Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 66. Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. UCB SA Basic Information, Manufacturing Base and Competitors
Table 68. UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Major Business
Table 69. UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Total Revenue (USD Million) (2018-2019)
Table 70. UCB SA SWOT Analysis
Table 71. UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Product and Services
Table 72. UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Regions (2015-2020)
Table 77. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 80. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries (2015-2020)
Table 82. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 84. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 90. South America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries (2015-2020)
Table 96. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 97. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Type (2015-2020)
Table 98. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Type (2015-2020) (USD Million)
Table 99. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Type (2015-2020)
Table 100. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 101. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Share by Application (2015-2020)
Table 102. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share Forecast by Regions (2021-2025)
Table 104. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share Forecast by Type (2021-2025)
Table 106. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Forecast by Application (2021-2025)
Table 107. Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Polyarticular Juvenile Idiopathic Arthritis Drug Picture
Figure 2. Global Sales Market Share of Polyarticular Juvenile Idiopathic Arthritis Drug by Type in 2019
Figure 3. Etanercept Biosimilar Picture
Figure 4. Tocilizumab Biosimilar Picture
Figure 5. Sarilumab Picture
Figure 6. Adalimumab Biosimilar Picture
Figure 7. Others Picture
Figure 8. Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Regions in 2018
Figure 41. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries in 2018
Figure 49. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries in 2018
Figure 51. United States Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Regions 2019
Figure 65. China Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries in 2019
Figure 72. South America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Polyarticular Juvenile Idiopathic Arthritis Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
全身型若年性特発性関節炎（JIA）治療の世界市場 2020年 Market Overview The global Systemic Idiopathic Juvenile Arthritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …- 若年性特発性関節炎治療の世界市場 2020年 Market Overview The global Juvenile Idiopathic Arthritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Juven…
- バイオシミラー薬品の世界市場 2020年 Market Overview The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 抗幼若ホルモン剤の世界市場 2020年 Market Overview The global Anti-juvenile Hormone Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-juvenile Ho…
- 若年性黄斑変性症治療の世界市場 2020年 Market Overview The global Juvenile Macular Degeneration Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Juven…